Literature DB >> 30569374

Total hip replacement-the cause of failure in patients under 50 years old?

Neil G Burke1, John P Gibbons2, Adrian J Cassar-Gheiti2, Fionnuala M Walsh2, James P Cashman2.   

Abstract

AIM: To establish the mode of failure of primary total hip replacement in patients under 50 years old.
METHODS: A total of 1062 revision total hip arthroplasties were performed over a 5-year period, with 146 on patients under 50 years old. These were subdivided into early (< 5 years) and late (> 5 years) failures from the index procedure.
RESULTS: The commonest mechanism of failure was aseptic loosening (42.3%) followed by metal-on-metal failure (15.8%), infection (14.4%) and instability (9.6%). The commonest cause of early revision surgery was due to metal-on-metal failure (27.8%) followed by aseptic loosening (19.7%) and infection (18.4%). In the late revision group, the main cause of failure was aseptic loosening (64%) and infection (10.7%).
CONCLUSION: The changing trend of early revision due to metal-on-metal failure is important to recognise. Continuous review of the mechanism of primary total hip replacement failure is necessary to ensure the best patient outcome and maximise implant survivorship.

Entities:  

Keywords:  Mode of failure; Revision total hip replacement; Total hip replacement

Mesh:

Year:  2018        PMID: 30569374     DOI: 10.1007/s11845-018-01956-8

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  2 in total

1.  Effects of continuous nursing based on WeChat platform on the functional recovery and quality of life in elderly patients after total hip arthroplasty.

Authors:  Juan Liu; Qiuyan Zhao; Juan Wang; Jing Zhang; Juan Jiang; Haoyu Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Overstretching Expectations May Endanger the Success of the "Millennium Surgery".

Authors:  Alwina Bender; Philipp Damm; Hagen Hommel; Georg N Duda
Journal:  Front Bioeng Biotechnol       Date:  2022-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.